Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.08 AUD | +1.46% | -2.80% | -0.48% |
04-03 | Mirvac Group Announces Resignation of Samantha Mostyn AO from Board | CI |
04-03 | Australian shares fall as financials and healthcare stocks drag | RE |
Summary
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The company appears to be poorly valued given its net asset value.
- This company will be of major interest to investors in search of a high dividend stock.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Analyst opinion has improved significantly over the past four months.
Weaknesses
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Diversified REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-0.48% | 5.28B | A | ||
-15.09% | 12.04B | B | ||
-12.99% | 7.51B | A | ||
-6.77% | 5.46B | A | ||
-9.70% | 5.15B | A- | ||
-1.80% | 4.54B | A- | ||
+0.51% | 4.5B | C+ | ||
-9.21% | 4.49B | C | ||
+3.97% | 3.86B | C | ||
-15.40% | 3.1B | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MGR Stock
- Ratings Mirvac Group